Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
28 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
166.7 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
USLD ARRAYADE CH DE LA COTE BASQUE
CENTRE HOSPITALIER AV CAM DE PRATS, 64100 BAYONNE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Brain : a journal of neurology · 2025
Abstract Biallelic loss-of-function mutations in the sorbitol dehydrogenase (SORD) gene cause the most common recessive type of Charcot-Marie-Tooth disease (CMT), CMT-SORD. However, the full genotype-phenotype spectrum and progression of the disease remain to be defined. Notably, a multicentre phase 2/3 study to test the efficacy of govorestat (NCT05397665), a new aldose reductase inhibitor, is currently ongoing. Diagnosing CMT-SORD will become imperative when disease-modifying therapies become available. In this cross-sectional multicentre study, we identified 144 patients from 126 families, including 99 males (69%) and 45 females (31%). Patients represented multiple ancestries, including European, Hispanic, Chinese, Near Eastern and Northern African. We confirmed c.757delG (p.Ala253GlnfsTer27) as the most common pathogenic allele, followed by c.458C>A (p.Ala153Asp), while other variants were identified, mostly in single cases. The average sorbitol level in CMT-SORD patients was significantly higher compared to controls and heterozygous carriers, independently from serum storage duration, sex or variant type. Two-thirds of cases were diagnosed with CMT2 while one-third had distal hereditary motor neuropathy. Disease onset was usually in the second decade of life. Although foot dorsiflexion was the most affected muscle group, dorsal and plantar flexion had a similar degree of weakness in most cases (difference of Medical Research Council score ≤ 1). One-fourth of patients used ankle foot orthoses, usually in their 30s, but most patients maintained independent ambulation later in life. Nerve conduction studies were suggestive of a motor predominant axonal neuropathy, with reduced conduction velocities in the intermediate range in a quarter of the cases. Sensory conductions in the upper limbs appeared more frequently affected than in the lower limbs. Foot dorsiflexion and plantar flexion decreased significantly with age. Male sex was significantly associated with the severity of distal lower limb weakness (plantar flexion) and a larger change over time (dorsiflexion). In conclusion, CMT-SORD is a frequent recessive form of axonal, motor predominant CMT, with prominent foot dorsiflexion and plantar flexion involvement. Fasting serum sorbitol is a reliable biomarker of the condition that can be utilized for pathogenicity assessment of identified rare SORD variants.
Brain : a journal of neurology · 2026
Abstract Charcot-Marie-Tooth disease type 1E (CMT1E) is a rare, autosomal dominant peripheral neuropathy caused by missense variants, deletions, and truncations within the peripheral myelin protein-22 (PMP22) gene. CMT1E phenotypes vary depending on the specific variant, ranging from mild to severe, and there is little natural history and phenotypic progression data on individuals with CMT1E. Patients with CMT1E were evaluated during initial and follow-up visits at sites within the Inherited Neuropathy Consortium. Clinical characteristics were obtained from history, neurological exams, and nerve conduction studies. Clinical outcome measures were used to quantify baseline and longitudinal changes, including the Rasch-modified CMT Examination Score version 2 (CMTESv2-R) and the CMT Pediatric Scale (CMTPedS). The trafficking of PMP22 variants in transfected cells was correlated to disease severity. Twenty-four presumed disease-causing PMP22 variants were identified in 50 individuals from 35 families, including 19 missense variants, three in-frame deletions, and two truncations. Twenty-nine patients presented with delayed walking during childhood. At their baseline evaluation, the mean CMTESv2-R in 46 patients was 16 ± 7.72 (out of 32), and the mean CMTPedS from 17 patients was 28 ± 6.35 (out of 44). Six individuals presented with hearing loss, eleven with scoliosis, three with hip dysplasia, and one with both scoliosis and hip dysplasia. Twenty variants were localized within transmembrane domains; 31 of 35 individuals with these variants had moderate to severe phenotypes. Three variants were found in the extracellular domain and were associated with milder phenotypes. Reduced expression of PMP22 at the cell surface, and the location of missense variants within the transmembrane domain correlated with disease severity. Pathogenic PMP22 variants located within the transmembrane regions usually cause a moderate to severe clinical phenotype, beginning in early childhood, and have impaired trafficking to the plasma membrane.
Journal of reproductive and infant psychology · 2026
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
The Journal of bone and joint surgery. American volume · 2026 · Journal Article
Di Laura A, Henckel J, Hart A
Journal of clinical medicine · 2026 · Journal Article
Pennacchioli E, Nespoli L, Piazzalunga D, Caliendo V, et al.
Neurocase · 2026 · Journal Article
Dominique ETH, Caroline K, Daniel GM, Tchokote SE, et al.
BMC medical imaging · 2026 · Journal Article
Balerdi G, Henckel J, Laura AD, Hart AJ, et al.
Journal of neurology, neurosurgery, and psychiatry · 2026 · Journal Article
Record CJ, Grider T, Rebelo AP, Laurini C, et al.
Brain : a journal of neurology · 2026 · Journal Article
Ward KS, Ptak CP, Pashkova N, Grider T, et al.
Journal of neurology · 2026 · Journal Article
Anna A, Giulia F, Sonia B, Laura F, et al.
Nature reviews. Disease primers · 2026 · Journal Article
Burns J, Timmerman V, Laurá M, Yiu EM, et al.
Cureus · 2026 · Journal Article
Ana Elena M, Oana Daniela T, Lucian Gheorghe P, Tiberiu Augustin G, et al.
Journal of cosmetic dermatology · 2026 · Journal Article
Eliana L, Anna P, Stefania B, Concetta S, et al.
Annals of agricultural and environmental medicine : AAEM · 2025 · Journal Article
Laura M, Ryszard P, Gruszczyńska MM
Archives of disease in childhood. Fetal and neonatal edition · 2025 · Letter
Agarwal A, Khan S, Johns M, McMahon CJ, et al.
Archives of physical medicine and rehabilitation · 2025 · Journal Article
Woodbury ML, Garner S, Hart E, Finetto P, et al.
Brain : a journal of neurology · 2025 · Journal Article
Cortese A, Dohrn MF, Curro R, Negri S, et al.
The Journal of arthroplasty · 2025 · Comparative Study
Carrier RE, Jake L, Grace ZT, Wakefield D, et al.
Scientific reports · 2026 · Journal Article
Marika M, Mariacristina P, Dorina Y, Benedetta R, et al.
Nutrients · 2026 · Journal Article
Laura T, Giorgio C, Sonia I, Paola M, et al.
Italian journal of pediatrics · 2026 · Journal Article
Elena F, Sofia N, Paola P, Laura P, et al.
Nutrients · 2026 · Journal Article
Laura T, Giorgio C, Sonia I, Paola M, et al.
BMC pregnancy and childbirth · 2025 · Journal Article
Stéphanie M, Laura V, Linh FK, Célia B, et al.
Journal of voice : official journal of the Voice Foundation · 2025 · Journal Article
Guarino P, Russo G, Chiari F, Barillari MR, et al.
Orphanet journal of rare diseases · 2026 · Journal Article
Francesca G, Michele S, Anna P, Paolo C, et al.
Intestinal Failure (New York, N.Y.) · 2025 · Journal Article
Héctor S, Laura OM, Diego R, Franco M, et al.
Trials · 2025 · Journal Article
Salsano G, Fiaschi P, Laura G, Sonia M, et al.
BMC veterinary research · 2025 · Journal Article
Diego P, Giada M, Nadia M, Carlo S, et al.
BMC pregnancy and childbirth · 2025 · Journal Article
Stéphanie M, Laura V, Linh FK, Célia B, et al.
Journal of voice : official journal of the Voice Foundation · 2025 · Journal Article
Guarino P, Russo G, Chiari F, Barillari MR, et al.
Journal of medical economics · 2025 · Journal Article
Paoletti M, Marcellusi A, Di Laura D, van den Puttelaar R, et al.
European journal of neurology · 2026 · Journal Article
Alessandro G, Giacomo B, Chiara R, Caterina L, et al.
Journal of reproductive and infant psychology · 2026 · Journal Article
Laura V, Ahmad M, Enrica S, Cristina S
BMC pregnancy and childbirth · 2025 · Journal Article
Stéphanie M, Laura V, Linh FK, Célia B, et al.
Head & neck · 2026 · Journal Article
David FB, Laura M, Alvaro S